The breakthrough Alzheimer’s device the FDA hasn’t approved - yet
PositiveFinancial Markets

Cerezen's innovative device has demonstrated encouraging results for some Alzheimer's patients and has recently received approval for use in Europe. This is significant as it highlights a potential new avenue for treatment in a field that desperately needs advancements. While the FDA has yet to approve it, the positive outcomes seen in Europe could pave the way for broader acceptance and usage, offering hope to many families affected by this challenging condition.
— Curated by the World Pulse Now AI Editorial System












